Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease
Yan-fang Hou, Chang Shan, Si-yue Zhuang, et al.
Microbiome (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders
Yijing Chen, Jinying Xu, Yu Chen
Nutrients (2021) Vol. 13, Iss. 6, pp. 2099-2099
Open Access | Times Cited: 546
Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
Zhe Zhao, Jingwen Ning, Xiu‐Qi Bao, et al.
Microbiome (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 379
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 255
Short-chain fatty acids in diseases
Dan Zhang, Yong‐Ping Jian, Yuning Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 211
Gut microbiota-derived metabolites mediate the neuroprotective effect of melatonin in cognitive impairment induced by sleep deprivation
Xintong Wang, Zixu Wang, Jing Cao, et al.
Microbiome (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 134
The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review
Julie-Anne Therese Matheson, R. M. Damian Holsinger
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1001-1001
Open Access | Times Cited: 58
Dimethyl itaconate ameliorates cognitive impairment induced by a high-fat diet via the gut-brain axis in mice
Wei Pan, Jinxiu Zhao, Jiacheng Wu, et al.
Microbiome (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 54
Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications
Junzhe Cheng, Hongkun Hu, Yumeng Ju, et al.
General Psychiatry (2024) Vol. 37, Iss. 1, pp. e101374-e101374
Open Access | Times Cited: 36
A review of machine learning and deep learning algorithms for Parkinson's disease detection using handwriting and voice datasets
Md Ariful Islam, Md. Ziaul Hasan Majumder, Md. Alomgeer Hussein, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25469-e25469
Open Access | Times Cited: 21
Microbiota-microglia crosstalk between Blautia producta and neuroinflammation of Parkinson's disease: A bench-to-bedside translational approach
Jiaming Liu, Xinhuang Lv, Tao Ye, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 270-282
Open Access | Times Cited: 18
Short-chain fatty acids: Important components of the gut-brain axis against AD
Yan Huang, Yi Feng Wang, Jing Miao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116601-116601
Open Access | Times Cited: 18
Akkermansia muciniphila and its metabolite propionic acid maintains neuronal mitochondrial division and autophagy homeostasis during Alzheimer’s disease pathologic process via GPR41 and GPR43
Zifan Wang, Cai Wang, Boyu Yuan, et al.
Microbiome (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective
Deepak Kumar, Mahendra Bishnoi, Kanthi Kiran Kondepudi, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 2
The Relationship Between the Gut Microbiome and Neurodegenerative Diseases
Xueling Zhu, Bo Li, Pengcheng Lou, et al.
Neuroscience Bulletin (2021) Vol. 37, Iss. 10, pp. 1510-1522
Open Access | Times Cited: 92
Spirulina platensis polysaccharides attenuate lipid and carbohydrate metabolism disorder in high-sucrose and high-fat diet-fed rats in association with intestinal microbiota
Tiantian Li, Zirui Huang, Rui‐Bo Jia, et al.
Food Research International (2021) Vol. 147, pp. 110530-110530
Closed Access | Times Cited: 86
Gut and Vaginal Microbiomes in PCOS: Implications for Women’s Health
Yuanyuan Gu, Guannan Zhou, Fangyue Zhou, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 64
Regulation of common neurological disorders by gut microbial metabolites
Jeongho Park, Chang H. Kim
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 12, pp. 1821-1833
Open Access | Times Cited: 63
The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
Ruiling Xu, Yuxuan Zhang, Shurui Chen, et al.
Critical Reviews in Microbiology (2022) Vol. 49, Iss. 2, pp. 151-176
Open Access | Times Cited: 56
Brain modulation by the gut microbiota: From disease to therapy
Sarmistha Mitra, Raju Dash, Amena Al Nishan, et al.
Journal of Advanced Research (2022) Vol. 53, pp. 153-173
Open Access | Times Cited: 54
Parkinson's Disease Is Associated with Impaired Gut–Blood Barrier for Short‐Chain Fatty Acids
Xiaodong Yang, Penghui Ai, Xiaoqin He, et al.
Movement Disorders (2022) Vol. 37, Iss. 8, pp. 1634-1643
Closed Access | Times Cited: 53
The Gut Microbiome as a Regulator of the Neuroimmune Landscape
Lewis W. Yu, Gulistan Agirman, Elaine Y. Hsiao
Annual Review of Immunology (2022) Vol. 40, Iss. 1, pp. 143-167
Open Access | Times Cited: 50
Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson’s disease patients
Gang Wu, Zhengli Jiang, Yaling Pu, et al.
BMC Neurology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 47
The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12289-12289
Open Access | Times Cited: 47
Propionate alleviates myocardial ischemia-reperfusion injury aggravated by Angiotensin II dependent on caveolin-1/ACE2 axis through GPR41
Fan Deng, Liang-Qing Zhang, Han Wu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 2, pp. 858-872
Open Access | Times Cited: 45
Role of gut microbiota-derived branched-chain amino acids in the pathogenesis of Parkinson’s disease: An animal study
Zhenzhen Yan, Fan Yang, Linlin Sun, et al.
Brain Behavior and Immunity (2022) Vol. 106, pp. 307-321
Closed Access | Times Cited: 42
Page 1 - Next Page

Scroll to top